Profile data is unavailable for this security.
About the company
Sisram Medical Ltd is an investment holding company principally engaged in the design, development, manufacture and distribution of energy cosmetic medicine and minimally invasive medical cosmetic treatment systems. The Company has a comprehensive medical cosmetic equipment portfolio, including medical beauty product line and life beauty product line, can be used for noninvasive medical cosmetic treatment, such as hair removal, rejuvenation, skin care, vascular treatment and pigmented lesions treatment, removal of tattoos, acne Treatment, fat reduction, body shaping and firming. The Company's medical cosmetic equipment can also be used for minimally invasive medical cosmetic treatment, such as private beauty treatment, laser liposuction, treatment of varicose veins and treatment of hyperhidrosis. The company sells its products in domestic and foreign markets.
- Revenue in HKD (TTM)2.81bn
- Net income in HKD246.11m
- Incorporated2013
- Employees1.08k
- LocationSisram Medical LtdOFEK 15 Building18 HaHarash Street, Industrial ParkCAESAREA 3079895IsraelISR
- Phone+972 46275357
- Websitehttps://sisram-medical.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Guanze Medical Infrm Indstry (Hldng) Ltd | 168.45m | 29.75m | 921.50m | 56.00 | 30.97 | 3.17 | 25.16 | 5.47 | 0.0313 | 0.0313 | 0.1773 | 0.3061 | 0.4876 | 5.37 | 1.20 | 3,007,980.00 | 8.72 | -- | 10.54 | -- | 54.72 | -- | 17.89 | -- | 6.25 | 2,148.22 | 0.0748 | -- | -11.88 | -- | 53.63 | -- | -- | -- |
| MicroTech Medical Hangzhou Co Ltd | 273.31m | -134.93m | 1.49bn | 760.00 | -- | 0.7579 | -- | 5.47 | -0.317 | -0.317 | 0.642 | 5.23 | 0.1137 | 2.35 | 4.13 | 359,612.90 | -5.62 | -- | -5.85 | -- | 49.13 | -- | -49.37 | -- | 21.22 | -- | 0.00008 | -- | 45.92 | -- | -256.75 | -- | -- | -- |
| ClouDr Group Ltd | 3.98bn | -348.68m | 1.55bn | 1.52k | -- | 0.7182 | -- | 0.3891 | -0.6445 | -0.6445 | 7.37 | 3.68 | 1.28 | 5.48 | 4.74 | 2,617,054.00 | -11.33 | -- | -17.13 | -- | 24.64 | -- | -8.87 | -- | 1.58 | -29.15 | 0.1314 | -- | 23.51 | -- | 80.87 | -- | -- | -- |
| Jenscare Scientific Co Ltd | 0.00 | -401.21m | 1.62bn | 376.00 | -- | 1.22 | -- | -- | -0.9617 | -0.9617 | 0.00 | 3.19 | 0.00 | -- | -- | 0.00 | -27.49 | -- | -28.61 | -- | -- | -- | -- | -- | 19.20 | -- | 0.0347 | -- | -- | -- | 15.38 | -- | -- | -- |
| PW Medtech Group Ltd | 728.61m | 165.33m | 1.72bn | 1.24k | 10.42 | 0.3946 | 5.26 | 2.36 | 0.1056 | 0.1056 | 0.4654 | 2.79 | 0.1331 | 2.19 | 9.21 | 585,700.20 | 4.04 | 7.23 | 4.91 | 8.09 | 56.42 | 58.13 | 30.37 | 85.38 | 12.70 | -- | 0.0002 | 4.11 | 25.75 | 16.78 | 44.46 | 5.94 | -7.92 | -- |
| Sisram Medical Ltd | 2.81bn | 246.11m | 1.79bn | 1.08k | 7.27 | 0.5062 | 4.86 | 0.6373 | 0.5253 | 0.5253 | 5.99 | 7.55 | 0.6147 | 1.80 | 4.39 | 2,599,311.00 | 5.63 | 5.94 | 6.70 | 6.88 | 61.10 | 57.66 | 9.16 | 10.58 | 2.00 | 13.96 | 0.0869 | 28.79 | 1.36 | 18.48 | -21.59 | 7.61 | 46.58 | 9.64 |
| IVD Medical Holding Ltd | 3.33bn | 257.05m | 1.82bn | 803.00 | 7.05 | 0.5028 | 6.12 | 0.5446 | 0.1901 | 0.1901 | 2.47 | 2.67 | 0.6788 | 2.78 | 5.62 | 4,151,013.00 | 5.21 | 5.18 | 6.86 | 6.67 | 21.75 | 20.75 | 7.68 | 7.53 | 1.56 | 7.53 | 0.0923 | -- | 12.35 | 49.49 | 13.41 | 18.15 | 19.77 | -- |
| Gaush Meditech Ltd | 1.52bn | 187.28m | 2.36bn | 869.00 | 12.63 | 1.30 | 8.80 | 1.56 | 1.27 | 1.27 | 10.25 | 12.26 | 0.5057 | 2.34 | 8.85 | 1,746,534.00 | 6.22 | -- | 8.35 | -- | 49.18 | -- | 12.30 | -- | 1.19 | 5.90 | 0.2814 | -- | 12.16 | -- | 149.63 | -- | -- | -- |
| Venus MedTech HangZhou Inc | 530.33m | -759.55m | 2.48bn | 865.00 | -- | 0.7863 | -- | 4.67 | -1.73 | -1.73 | 1.21 | 7.15 | 0.1014 | 0.9402 | 1.65 | 613,102.50 | -15.04 | -13.20 | -17.41 | -14.97 | 79.21 | 79.51 | -148.37 | -152.83 | 1.86 | -8.78 | 0.2206 | -- | 20.89 | 33.62 | 33.46 | -- | 58.20 | -- |
Data as of Jun 07 2024. Currency figures normalised to Sisram Medical Ltd's reporting currency: Hong Kong Dollar HKD
1.30%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Segall Bryant & Hamill LLCas of 30 Apr 2024 | 1.83m | 0.39% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2023 | 1.53m | 0.33% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 1.51m | 0.32% |
| Mellon Investments Corp.as of 09 May 2024 | 537.20k | 0.12% |
| SSgA Funds Management, Inc.as of 09 May 2024 | 397.60k | 0.09% |
| Atlantis Investment Management Ltd. /Hong Kong/as of 31 Dec 2023 | 206.80k | 0.04% |
| Guardians of New Zealand Superannuationas of 30 Jun 2023 | 57.60k | 0.01% |
| State of Wisconsin Investment Boardas of 31 Dec 2022 | 15.20k | 0.00% |
| Irish Life Investment Managers Ltd.as of 30 Jun 2023 | 5.33k | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd.as of 31 Dec 2023 | 800.00 | 0.00% |
More ▼
Data from 30 Jun 2023 - 06 Jun 2024Source: FactSet Research Systems Inc.
